Cargando…

Associations Between Cardiac Biomarkers and Cardiac Structure and Function in CKD

INTRODUCTION: Subclinical changes to cardiac structure and function detected with echocardiography precede the development of clinical heart failure (HF) in persons with chronic kidney disease (CKD). Circulating cardiac biomarkers may reflect these pathophysiological changes. This study investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stein, Nathan R., Zelnick, Leila R., Anderson, Amanda H., Christenson, Robert H., deFilippi, Christopher R., Deo, Rajat, Go, Alan S., He, Jiang, Ky, Bonnie, Lash, James P., Seliger, Stephen L., Soliman, Elsayed Z., Shlipak, Michael G., Bansal, Nisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335964/ https://www.ncbi.nlm.nih.gov/pubmed/32647762 http://dx.doi.org/10.1016/j.ekir.2020.04.031

Ejemplares similares

Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study
por: Bansal, Nisha, et al.
Publicado: (2019)

Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure
por: Tummalapalli, Sri Lekha, et al.
Publicado: (2020)

Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study
por: Lamprea‐Montealegre, Julio A., et al.
Publicado: (2019)

Cardiac Biomarkers and Risk of Mortality in CKD (the CRIC Study)
por: Wang, Ke, et al.
Publicado: (2020)

Prediction of Incident Heart Failure in CKD: The CRIC Study
por: Zelnick, Leila R., et al.
Publicado: (2022)

Kidney Function Specific Reference Limits for N-terminal Pro Brain Natriuretic Peptide and High Sensitivity Troponin T: The Systolic Blood Pressure Intervention Trial
por: Bansal, Nisha, et al.
Publicado: (2022)

Impact of Removing Race Variable on CKD Classification Using the Creatinine-Based 2021 CKD-EPI Equation
por: Ghuman, Jasleen K., et al.
Publicado: (2022)

Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis
por: deFilippi, Christopher R., et al.
Publicado: (2023)

High-Density Lipoprotein Lipidomics and Mortality in CKD
por: Lidgard, Benjamin, et al.
Publicado: (2023)

Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC)
por: Dubin, Ruth F, et al.
Publicado: (2013)

Vitamin D Metabolic Ratio and Risks of Death and CKD Progression
por: Bansal, Nisha, et al.
Publicado: (2019)

Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community‐Dwelling Population
por: Parikh, Ravi H., et al.
Publicado: (2016)

Cardiorespiratory Fitness and Highly Sensitive Cardiac Troponin Levels in a Preventive Medicine Cohort
por: DeFina, Laura F., et al.
Publicado: (2016)

Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study
por: Christenson, R.H., et al.
Publicado: (2019)

Natriuretic Peptide and Cardiovascular Risk: Is It About “U”?
por: deFilippi, Christopher R, et al.
Publicado: (2015)

Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High‐Sensitivity Troponin T, and N‐Terminal Pro–Brain‐Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction
por: Lidgard, Benjamin, et al.
Publicado: (2022)

Urinary EGF and MCP-1 and risk of CKD after cardiac surgery
por: Menez, Steven, et al.
Publicado: (2021)

Association of the Estimated Glomerular Filtration Rate With vs Without a Coefficient for Race With Time to Eligibility for Kidney Transplant
por: Zelnick, Leila R., et al.
Publicado: (2021)

Clinical Application of Serologic Testing for Coronavirus Disease 2019 in Contemporary Cardiovascular Practice
por: Damluji, Abdulla A., et al.
Publicado: (2021)

Proteomics of CKD progression in the chronic renal insufficiency cohort
por: Dubin, Ruth F., et al.
Publicado: (2023)

Deoxycholic Acid and Risks of Cardiovascular Events, ESKD, and Mortality in CKD: The CRIC Study
por: Frazier, Rebecca, et al.
Publicado: (2021)

Body Composition Changes Following Dialysis Initiation and Cardiovascular and Mortality Outcomes in CRIC (Chronic Renal Insufficiency Cohort): A Bioimpedance Analysis Substudy
por: Wang, Ke, et al.
Publicado: (2021)

Evaluation of plasma sphingolipids as mediators of the relationship between kidney disease and cardiovascular events
por: Lidgard, Benjamin, et al.
Publicado: (2023)

Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients
por: Hallan, Stein, et al.
Publicado: (2017)

Cardiac Mechanics and Kidney Function Decline in the Cardiovascular Health Study
por: Mehta, Rupal, et al.
Publicado: (2023)

Incident Atrial Fibrillation and Risk of Dementia in a Diverse, Community‐Based Population
por: Bansal, Nisha, et al.
Publicado: (2023)

Post-cardiac arrest evaluation: understanding non-shockable rhythms
por: Hyman, Matthew C, et al.
Publicado: (2019)

Cardiac Amyloidosis: The “Tipping Point” Has Been Reached
por: Witteles, Ronald, et al.
Publicado: (2021)

Effectiveness and Utilization of Cardiac Rehabilitation Among People With CKD
por: Thompson, Stephanie, et al.
Publicado: (2021)

Cardiac-specific renalase overexpression alleviates CKD-induced pathological cardiac remodeling in mice
por: Wang, Yi, et al.
Publicado: (2022)

“Malignant” Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi‐Ethnic Study of Atherosclerosis)
por: Peters, Matthew N., et al.
Publicado: (2018)

Association of Kidney Function With Risk of Adverse Effects of Therapies for Atrial Fibrillation
por: Bansal, Nisha, et al.
Publicado: (2022)

Magnesium and Cardiovascular Disease in CKD: The Mysteries of a Humble Divalent Cation
por: Kula, Alexander J., et al.
Publicado: (2021)

The Role of Cardiac Biomarkers in the Diagnosis and Management of Patients Presenting with Suspected Acute Coronary Syndrome
por: Christenson, Eric, et al.
Publicado: (2013)

Age‐adapted eGFR thresholds underestimate the risks beyond kidney failure associated with CKD in older populations
por: Lees, Jennifer S., et al.
Publicado: (2022)

Cardiac biomarkers in pediatric CKD—a prospective follow-up study
por: Lindblad, Ylva Tranæus, et al.
Publicado: (2022)

Cardiac Disease Patterns in Northern Malawi: Epidemiologic Transition Perspective
por: Soliman, Elsayed Z., et al.
Publicado: (2008)

Editorial: Case reports in cardiac rhythmology: 2022
por: Ballatore, Andrea, et al.
Publicado: (2023)

Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study
por: Leidner, Alexander S., et al.
Publicado: (2023)

Joint effect of highly-sensitive cardiac troponin T and ankle-brachial index on incident cardiovascular events: The MESA and CHS
por: Tedla, Yacob G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_duf2o1fm7num7lnvqj25j6td4n